Department of Haematology Research Laboratory
Aalborg University Hospital
6 December 2021 On Friday 3 December MD Andreaas Kiesbye Øvlisen defended his PhD with the title: “Socioeconomic impact of lymphoma with focus on fertility and mental health using Danish nationwide registers”
Last row: Jane, Martin, Joachim, Helle, Simon, Rasmus K., Jonas, Anne Charles, Heidi, Rasmus F,Front row: Andreas, Lise, Karen, Marianne, Issa, Pernille, Anja, Paw
23 April 2021 On Friday 23 April 2021 cand.scient Marijana Nesic defended her PhD with the title: “The role of genetic alterations and immune surveillance in diffuse large B-cell lympoma” Read more here
15 April 2021 Martin Bøgsted and Tarec Christoffer El-Galaly have each received a grant from Kræftens Bekæmpelse. Martin Bøgsted has received DKK 625,000 for the project “Ulighed i adgangen til medicinsk kræftbehandling: Hvad kan vi lære og ændre ud fra individ-baserede Read more
16 November 2020 On Thursday 12 November 2020 M.Sc. (Molecular Medicine) Hanne Due defended her PhD with the title: “Investigation of drug response in diffuse large B-cell lymphoma” Read more here
6 November 2020 On Thursday 5 November 2020 cand.scient.san. Mia Sommer defended her PhD with the title: “Patient-reported outcomes on the trajectory of hematological cancer, a multi-method study” Read more here
29 October 2020 Karen Dybkær was interviewed for the Radio4 programme, Techtopia – a programme about technology where CRISPR was the topic and made in collaboration with the engineering association IDA. Learn more here
10 September 2020 Charles Vesteghem and Martin Bøgsted have developed a database, which collects all clinical information about the patient’s cancer disease including genetic analyses of cancer tumours and information about the treatment. Read more here and here
6 October 2020 By using the genome-editing technique CRISPR/Cas9, researchers from the research section at the Department of Haematology investigate chemotherapy resistance in cancer cells. Treatment resistance is a major clinical challenge, and by using this technology we aim at improving the Read more
8 June 2020 Karen Dybkær and Marianne Tang Severinsen have each received a grant from Karen Elise Jensen. Karen Dybkær has received DKK 3.000.000 from Karen Elise Jensen Fonden for the project “Behandlingsresistens i maligne B-celle blodsygdomme – kombination af CRISPR-baseret Read more